AIM IMMUNOTECH INC. Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit
AIM IMMUNOTECH INC. (AIM) reported Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit of $0.34 per share for the 1-month period ending 2017-09-30, per its 10-Q filed 2017-11-14.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit · last filed 2017-11-14
- AIM IMMUNOTECH INC. share-based payment arrangement, option, exercise price range, lower range limit for the quarter ending 2013-03-31 was $0.26.
| Period end | Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit 0 month | Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit 1 month | Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit 3 month | Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit 6 month | Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit 9 month |
|---|---|---|---|---|---|
| 2017-09-30 | $0.34 10-Q · filed 2017-11-14 | ||||
| 2017-06-15 | $0.36 10-Q · filed 2017-11-14 | ||||
| 2017-04-30 | $0.36 10-Q · filed 2017-11-14 | ||||
| 2013-09-30 | $0.23 10-Q · filed 2013-11-08 | ||||
| 2013-06-30 | $0.26 10-Q · filed 2013-08-09 | ||||
| 2013-03-31 | $0.26 10-Q · filed 2013-05-08 | ||||
| 2012-09-30 | $0.25 10-Q · filed 2012-11-02 | ||||
| 2012-06-30 | $0.25 10-Q · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |